Ombitasvir and paritaprevir boosted with ritonavir and combined with dasabuvir for chronic hepatitis C. [electronic resource]
Producer: 20180319Description: 559-567 p. digitalISSN:- 1747-4132
- 2-Naphthylamine
- Administration, Oral
- Anilides -- administration & dosage
- Antiviral Agents -- administration & dosage
- Carbamates -- administration & dosage
- Cyclopropanes
- Drug Combinations
- Drug Interactions
- Drug Resistance, Viral
- Drug Therapy, Combination
- Genotype
- Hepacivirus -- drug effects
- Hepatitis C, Chronic -- diagnosis
- Humans
- Lactams, Macrocyclic
- Macrocyclic Compounds -- administration & dosage
- Proline -- analogs & derivatives
- Ritonavir -- administration & dosage
- Sulfonamides -- adverse effects
- Sustained Virologic Response
- Treatment Outcome
- Uracil -- adverse effects
- Valine
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.